Summit Trail Advisors, LLC Shattuck Labs, Inc. Transaction History
Summit Trail Advisors, LLC
- $3 Billion
- Q1 2025
A detailed history of Summit Trail Advisors, LLC transactions in Shattuck Labs, Inc. stock. As of the latest transaction made, Summit Trail Advisors, LLC holds 22,000 shares of STTK stock, worth $22,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,000Holding current value
$22,000% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding STTK
# of Institutions
77Shares Held
31.4MCall Options Held
0Put Options Held
0-
Prosight Management, LP Dallas, TX6.64MShares$6.64 Million2.39% of portfolio
-
Redmile Group, LLC San Francisco, CA5.54MShares$5.54 Million0.52% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.68MShares$4.68 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.47MShares$2.47 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.41MShares$2.41 Million0.0% of portfolio
About Shattuck Labs, Inc.
- Ticker STTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,382,000
- Market Cap $42.4M
- Description
- Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...